Back to homepage

Tag "Glenmark Pharmaceuticals"

Glenmark to make, market SaNOtize’s nasal spray against Covid-19

Glenmark to make, market SaNOtize’s nasal spray against Covid-19

🕔16:09, 2.Aug 2021

Chennai, Aug 2  Pharma major Glenmark Pharmaceuticals Ltd on Monday said it has signed a long term partnership with Canandian company SaNOtize Research & Development Corp., to manufacture, market and distribute Nitric Oxide Nasal Spray (NONS) for Covid-19 treatment. According

Read Full Article
Glenmark launches dry powder inhaler Tiogiva in UK

Glenmark launches dry powder inhaler Tiogiva in UK

🕔14:48, 15.Jun 2021

Chennai, June 15  Pharma major Glenmark Pharmaceuticals Ltd on Tuesday said it has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name – Tiogiva, in UK for the treatment of chronic obstructive pulmonary disease

Read Full Article
Glenmark announces 400 mg ‘FabiFlu’ for Covid-19 treatment

Glenmark announces 400 mg ‘FabiFlu’ for Covid-19 treatment

🕔18:57, 6.Aug 2020

New Delhi, Aug 6 Glenmark Pharmaceuticals, a research-led global pharmaceutical company, on Thursday announced that it is set to introduce a 400 mg version of oral antiviral – FabiFlu — for the treatment of mild to moderate Covid-19 in India. It

Read Full Article
Glenmark to start trial combining 2 anti-viral drugs on India Covid patients

Glenmark to start trial combining 2 anti-viral drugs on India Covid patients

🕔16:21, 26.May 2020

New Delhi, May 26  Glenmark Pharmaceuticals announced on Tuesday that it will commence another new Phase 3 clinical trial on a combination of two anti-viral drugs Favipiravir and Umifenovir in hospitalized patients of moderate COVID-19 in India. Glenmark has received

Read Full Article

Search the Website

Advertiser’s Logo